UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 535

Sortiert nach

Fifty years of lipoprotein(a) – the Magical Mystery Tour continues

Journal of internal medicine, 2013-01, Vol.273 (1), p.3-5

Angelin, B

2013

Link zum Volltext

Verfügbarkeit prüfen

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19

Journal of internal medicine, 2011-12, Vol.270 (6), p.580-588

2011

Link zum Volltext

Verfügbarkeit prüfen

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

Journal of internal medicine, 2006-12, Vol.260 (6), p.530-536

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C‐III

Journal of internal medicine, 2017-06, Vol.281 (6), p.575-585

2017

Link zum Volltext

Verfügbarkeit prüfen

Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels

Journal of internal medicine, 2016-05, Vol.279 (5), p.477-484

2016

Link zum Volltext

Verfügbarkeit prüfen

Interstitial postprandial hyperlipidemia and remnant lipoproteins in type 2 diabetes mellitus

ATHEROSCLEROSIS, 2021-08, Vol.331, p.e7-e7

2021

Link zum Volltext

Verfügbarkeit prüfen

Murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism

ATHEROSCLEROSIS, 2021-08, Vol.331, p.e128-e128

2021

Link zum Volltext

Verfügbarkeit prüfen

Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism

Journal of internal medicine, 2018-11, Vol.284 (5), p.546-559

2018

Link zum Volltext

Verfügbarkeit prüfen

Sex-specific metabolic changes during estrogen receptor beta activation in obesity

ATHEROSCLEROSIS, 2020-12, Vol.315, p.e87-e87

2020

Link zum Volltext

Verfügbarkeit prüfen

Founder effects facilitate the use of a genotyping‐based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia

Journal of internal medicine, 2021-08, Vol.290 (2), p.404-415

2021

Link zum Volltext

Verfügbarkeit prüfen

Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome

Journal of internal medicine, 2020-05, Vol.287 (5), p.534-545

2020

Link zum Volltext

Verfügbarkeit prüfen

Can LDL cholesterol be too low? Possible risks of extremely low levels

Journal of internal medicine, 2017-06, Vol.281 (6), p.534-553

2017

Link zum Volltext

Verfügbarkeit prüfen

Nutrition and stem cell integrity in aging

Journal of internal medicine, 2022-10, Vol.292 (4), p.587-603

2022

Link zum Volltext

Verfügbarkeit prüfen

Maternal obesity provokes hepatic lipidic modulations in offspring in a sex-dependent manner

ATHEROSCLEROSIS, 2020-12, Vol.315, p.e86-e86

2020

Link zum Volltext

Verfügbarkeit prüfen

Posttranscriptional regulation of the LDLR by ACTH treatment – Importance of PCSK9 in liver while idol takes the scene in the adrenals

Atherosclerosis, 2016-09, Vol.252, p.e197-e197

2016

Link zum Volltext

Verfügbarkeit prüfen

Unique case of cerebrotendinous xanthomatosis revisited: All the mutations responsible for this disease are present in the CYP27A1 gene

Journal of internal medicine, 2018-06, Vol.283 (6), p.604-606

2018

Link zum Volltext

Verfügbarkeit prüfen

Myocardial microvascular dysfunction in asymptomatic patients with hereditary dyslipidemia

EUROPEAN HEART JOURNAL, 2023-11, Vol.44 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system

European journal of clinical investigation, 2006-02, Vol.36 (2), p.98-104

2006

Link zum Volltext

Verfügbarkeit prüfen

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice

The Journal of clinical investigation, 2001-03, Vol.107 (5), p.565-573

2001

Link zum Volltext

Verfügbarkeit prüfen

Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans

Journal of internal medicine, 2013-09, Vol.274 (3), p.227-232

2013

Link zum Volltext

Verfügbarkeit prüfen

Bile acids and lipoprotein metabolism: Effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression

Biochemical and biophysical research communications, 2007-06, Vol.357 (3), p.707-711

2007

Link zum Volltext

Verfügbarkeit prüfen

Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism[S]

Journal of lipid research, 2020-04, Vol.61 (4), p.480-491

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating Fibroblast Growth Factors as Metabolic Regulators—A Critical Appraisal

Cell metabolism, 2012-12, Vol.16 (6), p.693-705

2012

Link zum Volltext

Verfügbarkeit prüfen

Mental distress in treatment seeking young adults (18–25 years) with severe obesity compared with population controls of different body mass index levels: cohort study

Clinical obesity, 2017-02, Vol.7 (1), p.1-10

2017

Link zum Volltext

Verfügbarkeit prüfen

Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist

Cell metabolism, 2013-02, Vol.17 (2), p.225-235

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 535

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(465)
Mit Volltextzugriff
(394)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Fifty years of lipoprotein(a) – the Magical Mystery Tour continues

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C‐III

Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels

Interstitial postprandial hyperlipidemia and remnant lipoproteins in type 2 diabetes mellitus

Murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism

Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism

Sex-specific metabolic changes during estrogen receptor beta activation in obesity

Founder effects facilitate the use of a genotyping‐based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia

Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome

Can LDL cholesterol be too low? Possible risks of extremely low levels

Nutrition and stem cell integrity in aging

Maternal obesity provokes hepatic lipidic modulations in offspring in a sex-dependent manner

Posttranscriptional regulation of the LDLR by ACTH treatment – Importance of PCSK9 in liver while idol takes the scene in the adrenals

Unique case of cerebrotendinous xanthomatosis revisited: All the mutations responsible for this disease are present in the CYP27A1 gene

Myocardial microvascular dysfunction in asymptomatic patients with hereditary dyslipidemia

Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice

Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans

Bile acids and lipoprotein metabolism: Effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression

Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism[S]

Circulating Fibroblast Growth Factors as Metabolic Regulators—A Critical Appraisal

Mental distress in treatment seeking young adults (18–25 years) with severe obesity compared with population controls of different body mass index levels: cohort study

Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist

Suchergebnisse filtern